Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene

BMC Medical Genetics

Research Article

Per Kogner¹  Anna Djos²  Tommy Martinsson²  Susanne Fransson² 

[1] Childhood Cancer Research Unit, Department of Woman and Child Health, Karolinska Institute, Karolinska University Hospital, SE-17176, Stockholm, Sweden;Department of Clinical Genetics, Institute of Biomedicine, University of Gothenburg, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden;

关键词: Neuroblastoma;    STAG2;    Aneuploidy;    Numerical aberrations;    Chromosomal instability;   

DOI  :  10.1186/1471-2350-14-102

 received in 2013-03-04, accepted in 2013-09-23,  发布年份 2013

来源: Springer

【 摘 要 】

BackgroundChromosomal instability is a hallmark of human cancer caused by errors in mitotic control and chromosome segregation. STAG2 encodes a subunit of the cohesion complex that participates in mitotic chromatid separation and was recently found to show low expression and inactivating mutations in Ewing’s sarcoma, melanoma and glioblastoma.In the childhood tumor neuroblastoma (NB) segmental chromosomal alterations are associated with poor prognosis whereas tumors displaying whole chromosome gains and losses have a much better prognosis.MethodAs the genetic contribution to aneuploidy is unknown in NB, we investigated the presence of STAG2 mutations through sequence analysis of all 33 coding exons in 37 primary NB tumors.Results and conclusionAs no STAG2 mutation was detected in this study, we conclude that inactivating mutation of STAG2 is not likely causative to neuroblastoma aneuploidy.

【 授权许可】

Unknown   
© Djos et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.